The Global Genes NEXT 2022: Redefining the Possible report, is an annual reflection on the status of innovation and progress in rare diseases, including a comprehensive collection of data, studies, and key findings published throughout 2021 from leading global rare disease stakeholders outlining advancements in rare diseases and what comes next.

The report covers an aggregate of rare disease trends, highlights, and commentary from leaders in the industry. The report also outlines progress made in rare disease research, diagnosis, development, regulation, funding, and treatment.

The NEXT Report was written by Daniel S. Levine.